Press/Media
- 200 - 225 out of 1,939 results
Search results
-
La UB és la universitat de l’Estat amb més investigadors entre els més influents del món
21/11/24
1 item of Media coverage
Press/Media
-
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to offer joint Ph.D. program in health sciences engineering
Vashishth,, D., Charney, D. & Balchandani, P.
20/11/24
1 item of Media coverage
Press/Media
-
Mount Sinai Health System: Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to Offer Joint PhD Program in Health Sciences Engineering
Vashishth,, D. & Balchandani, P.
20/11/24
1 item of Media coverage
Press/Media
-
PreciseDx Announces Formation of Scientific Advisory Board
Cordon-Cardo,, C. & Sparano, J.
20/11/24
4 items of Media coverage
Press/Media
-
PreciseDx Announces Formation of Scientific Advisory Board
Cordon-Cardo,, C. & Sparano, J.
20/11/24
1 item of Media coverage
Press/Media
-
Rensselaer Polytechnic Institute and the Icahn School of Medicine at Mount Sinai to Offer Joint PhD Program in Health Sciences Engineering
Vashishth,, D., Charney, D. & Balchandani, P.
20/11/24
2 items of Media coverage
Press/Media
-
Clinical Trial: Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
19/11/24
2 items of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai in the Area of Thyroid Cancer Reported (Pathologic Characteristics and Surgical Outcomes of Pediatric Versus Adult Well-differentiated Thyroid Cancer)
Kumar, A., van Gerwen, M., Kirke,, D. & Roof, S.
19/11/24
1 item of Media coverage
Press/Media
-
Nine researchers from the Clínic-IDIBAPS among the most highly cited researchers according to Clarivate Analytics
19/11/24
1 item of Media coverage
Press/Media
-
Weekly: Karyopharm Therapeutics (KPTI: 81.40c) shares post worst week in eleven weeks; -6.28c [7.2%]
16/11/24
1 item of Media coverage
Press/Media
-
Drug delays tumour growth in models of children's liver cancer
15/11/24
1 item of Media coverage
Press/Media
-
NYU Langone Hospitals: Remote Telemedicine Tool Found Highly Accurate in Diagnosing Melanoma
14/11/24 → 15/11/24
3 items of Media coverage
Press/Media
-
Remote Telemedicine Tool Found Highly Accurate In Diagnosing Melanoma
14/11/24
1 item of Media coverage
Press/Media
-
Remote Telemedicine Tool Found Highly Accurate In Diagnosing Melanoma
14/11/24
72 items of Media coverage
Press/Media
-
Reports Summarize Sensor Research Study Results from Icahn School of Medicine at Mount Sinai (Radiofrequency Enhancer to Recover Signal Dropouts in 7 Tesla Diffusion MRI)
Verma, G., Balchandani, P. & Alipour, A.
14/11/24
1 item of Media coverage
Press/Media
-
Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval for PSMA-Fluorescent Novel Drug AS1986NS
13/11/24
1 item of Media coverage
Press/Media
-
First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
13/11/24
1 item of Media coverage
Press/Media
-
The Tisch Cancer Institute at Mount Sinai Highlights Key Developments for Lung Cancer Awareness Month 2024
Hirsch, F., Hirsch, F., Henschke, C., Flores, R. & Taioli, E.
13/11/24
1 item of Media coverage
Press/Media
-
Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval For PSMA-Fluorescent Novel Drug AS1986NS
12/11/24
68 items of Media coverage
Press/Media
-
-Aptevo Therapeutics - First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
11/11/24 → 12/11/24
3 items of Media coverage
Press/Media
-
Antelope Surgical Solutions Achieves Commercial Investigational New Drug (IND) Approval For PSMA-Fluorescent Novel Drug AS1986NS
12/11/24
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai Have Provided New Information about Radical Cystectomy (Undetectable Pre-radical Cystectomy Circulating Tumour Dna Status Predicts Improved Oncological Outcomes)
Mehrazin,, R., Sfakianos, J., Wiklund, P. & Attalla, K.
12/11/24
1 item of Media coverage
Press/Media
-
First-in-Class Bispecific Antibody, ALG.APV-527, Meets Important Trial Endpoints in Phase 1 Solid Tumor Trial
11/11/24
12 items of Media coverage
Press/Media
-
08:43 EST Aptevo announces ALG.APV-527 meets trial endpoints in Phase 1 study
11/11/24
1 item of Media coverage
Press/Media